REGN vs. MRK
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or MRK.
Correlation
The correlation between REGN and MRK is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. MRK - Performance Comparison
Key characteristics
REGN:
-1.48
MRK:
-1.46
REGN:
-2.13
MRK:
-1.97
REGN:
0.74
MRK:
0.73
REGN:
-0.76
MRK:
-0.95
REGN:
-1.46
MRK:
-1.83
REGN:
27.12%
MRK:
19.35%
REGN:
26.80%
MRK:
24.33%
REGN:
-91.81%
MRK:
-68.62%
REGN:
-52.22%
MRK:
-37.29%
Fundamentals
REGN:
$62.69B
MRK:
$205.80B
REGN:
$38.36
MRK:
$6.74
REGN:
14.95
MRK:
12.09
REGN:
0.91
MRK:
0.79
REGN:
$11.06B
MRK:
$48.39B
REGN:
$9.40B
MRK:
$39.64B
REGN:
$3.94B
MRK:
$19.98B
Returns By Period
In the year-to-date period, REGN achieves a -19.39% return, which is significantly lower than MRK's -17.40% return. Over the past 10 years, REGN has underperformed MRK with an annualized return of 2.66%, while MRK has yielded a comparatively higher 7.29% annualized return.
REGN
-19.39%
-16.55%
-43.31%
-38.72%
3.09%
2.66%
MRK
-17.40%
-11.82%
-24.54%
-34.29%
5.49%
7.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. MRK — Risk-Adjusted Performance Rank
REGN
MRK
REGN vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. MRK - Dividend Comparison
REGN's dividend yield for the trailing twelve months is around 0.15%, less than MRK's 3.88% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.88% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
REGN vs. MRK - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for REGN and MRK. For additional features, visit the drawdowns tool.
Volatility
REGN vs. MRK - Volatility Comparison
Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 11.68% compared to Merck & Co., Inc. (MRK) at 8.87%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities